Alvaro Angel, the recently appointed general manager of the pharmaceutical division of Bayer Mexico, provides insights into the rapidly evolving local pharma market, and documents Bayer Mexico’s ambitious growth strategy; with the affiliate already standing out as one of the most important of the group at a global level.
You took over the helm of the pharma division of Bayer Mexico in January 2016, after having headed Bayer’s footprint in Venezuela, Ecuador, and Peru over the last ten years. What have been your first impressions when joining the Mexican affiliate?
"In Mexico, three different players are now competing in the private sector: pharmacy chains’ private labels, generics, and innovators."
